Monsanto Co. and Albaugh LLC announced Tuesday that both companies have entered into a royalty-beating license agreement that allows Albaugh to make and sell specific glyphosate formulations in the United States, Canada, and Europe.
“For years, Albaugh has been a valued partner in providing crop protection choices that help farmers,” Monsanto’s Vice President for Commercial Operations Mike Frank said. “These specific formulations offer many benefits to end-use customers, including improved efficacy, storage and handling properties – all important advancements as glyphosate remains the cornerstone of farmers’ diversified weed management programs.”
Allbaugh will immediately introduce its potassium glyphosate products in the U.S. and Canada, and initiate the registration process for future introductions in Europe.
“We are pleased with this agreement and the opportunity to further strengthen Albaugh’s portfolio of glyphosate product offerings,” Albaugh Group CEO Kurt Pedersen Kaalund said.
Organizations in this story
Albaugh, LLC 1525 Northeast 36th Street Ankeny, IA 50021
- Montana lawmakers preserve private-road rights
- Nevada cautions horse owners after reports of EHV-4, strangles
- American Farm Bureau Federation outlines concerns at USDA forum
- Kansas looks for beef trade mission participants
- Project to introduce drought-resistant maize continues in Africa
- American Soybean Association outlines its concerns on Farm Bill
- Commodity Classic set to kick off in San Antonio
- Second-graders enjoy a day of 'Ag Venture'
- Florida offers potentially life-saving app
- Connecticut hopes third time's a charm for conservationists